These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23833234)

  • 1. Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis.
    Kant CD; Akiyama Y; Tanaka K; Shea S; Connolly SE; Germana S; Winn HJ; LeGuern C; Tocco G; Benichou G
    J Immunol; 2013 Aug; 191(4):1948-56. PubMed ID: 23833234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
    Han WR; Murray-Segal LJ; Mottram PL
    Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone.
    Yin D; Dujovny N; Ma L; Varghese A; Shen J; Bishop DK; Chong AS
    J Immunol; 2003 Jan; 170(2):853-60. PubMed ID: 12517950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells.
    Nasr IW; Wang Y; Gao G; Deng S; Diggs L; Rothstein DM; Tellides G; Lakkis FG; Dai Z
    J Immunol; 2005 May; 174(10):6161-8. PubMed ID: 15879112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
    Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
    Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
    Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CD8+ T cell-derived CD40 signals is necessary but not sufficient for Foxp3+ induced regulatory T cell generation in vivo.
    Liu D; Ferrer IR; Konomos M; Ford ML
    J Immunol; 2013 Aug; 191(4):1957-64. PubMed ID: 23858029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of protein kinase C-theta facilitates tolerance induction.
    Wang L; Xiang Z; Ma LL; Chen Z; Gao X; Sun Z; Williams P; Chari RS; Yin DP
    Transplantation; 2009 Feb; 87(4):507-16. PubMed ID: 19307786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.